Rexahn Pharmaceuticals, Inc. logo

REXN

Rexahn Pharmaceuticals, Inc. · NASDAQ

Rexahn Pharmaceuticals, Inc. (REXN) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for REXN in the last 30 days. The most recent was published Mar 27, 2023.

Latest news

5 items

REXN FAQ

6 questions
  • What is the latest news on REXN?
    Quantisnow has not tracked any new filings, ratings or press releases for REXN in the last 30 days. The most recent wire item was published on March 27, 2023.
  • Where does REXN stock trade?
    Rexahn Pharmaceuticals, Inc. (REXN) is listed on NASDAQ.
  • What sector and industry is REXN in?
    Rexahn Pharmaceuticals, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
  • When did Rexahn Pharmaceuticals, Inc. go public?
    Rexahn Pharmaceuticals, Inc. (REXN) completed its IPO in n/a.
  • What companies are similar to REXN?
    Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare REXN side-by-side with any of them on Quantisnow.
  • How can I track REXN on Quantisnow?
    Quantisnow aggregates Rexahn Pharmaceuticals, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow REXN to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change